Which hedge funds own CERE1EUR? CEREVEL THERAPEUTICS HLDNG I, Q2 2026 13F holders
0 tracked hedge funds disclosed a position in CERE1EUR (CEREVEL THERAPEUTICS HLDNG I) in their Q2 2026 13F filings, worth $0 in total.
- 0
- Holders
- 0
- New this quarter
- 0
- Exited this quarter
- $0
- Combined value
- –
- Share of managers holding
Holders, Q2 2026
Ownership over time
By quarter
| Quarter | Holders | Managers filing | Share holding | Combined value |
|---|---|---|---|---|
| Q3 2024 | 0 | 73 | 0.0% | $0 |
| Q2 2024 | 7 | 73 | 9.6% | $292m |
| Q1 2024 | 7 | 73 | 9.6% | $307m |
| Q4 2023 | 7 | 73 | 9.6% | $114m |
| Q3 2023 | 3 | 73 | 4.1% | $26.2m |
| Q2 2023 | 3 | 73 | 4.1% | $63.4m |
| Q1 2023 | 3 | 73 | 4.1% | $35.6m |
| Q4 2022 | 3 | 73 | 4.1% | $60.9m |
| Q3 2022 | 4 | 74 | 5.4% | $81.1m |
| Q2 2022 | 3 | 74 | 4.1% | $44.1m |
| Q1 2022 | 3 | 74 | 4.1% | $72.4m |
| Q4 2021 | 2 | 74 | 2.7% | $69.6m |
| Q3 2021 | 3 | 71 | 4.2% | $102m |
| Q2 2021 | 5 | 71 | 7.0% | $139m |
| Q1 2021 | 4 | 70 | 5.7% | $63.7m |
| Q4 2020 | 3 | 71 | 4.2% | $67.5m |
Who discovered CERE1EUR first?
Earliest meaningful positions among the 13 tracked managers seen opening CERE1EUR since Q4 2020.
| Melqart Asset Management (UK) Ltd | Q4 2023 | 1.0% | Exited by Q3 2024 | −3.6% |
| Soros Fund Management | Q1 2024 | 1.9% | Exited by Q3 2024 | −3.3% |
| Pentwater Capital Management LP | Q4 2023 | 0.9% | Exited by Q3 2024 | −3.6% |
Stock since is the split-adjusted change in the quarter-end price, excluding dividends, from the first reported quarter: the price the 13F filings themselves imply (value ÷ shares), blank across any gap that cannot be accounted for. It describes the stock, not the return any manager earned.